Macular Degeneration Foundation
Interviewing and bringing information about new and upcoming treatments for Macular Degeneration straight from the researchers and clinical trial doctors to the public. Creating awareness, education, information and support to the macular degeneration community.
Revolutionary AR Glasses for Vision Loss: EYE6with Ivy AI assist
Stem Cell Transplants for Dry AMD
AREDS Vitamin Formula and Nutrition for Slowing Progression of AMD
OCT biomarkers predictive of visual deficit measured by microperimetry at 24 months in OAKS trial
Bruch's Membrane Calcification: Comparing Histopathology and Clinical Imaging
Genomic and molecular underpinnings of AMD
Positive Results from Randomized Controlled Trials of MCO-10 Gene Therapy for RP & Stargardt
MCO-020 Gene Therapy for Macular Degeneration and GA
Analysis of AMD and Late-Onset Alzheimer's Disease Reveals Shared Genetic Architecture
eSight Go
Genetic link of eye diseases in multi-generational African Families
Utilization of Eye Care in Western New York – A Guidance to Improve
Decoding Genome-wide miRNA Signatures in Human Donor Eye Tissue in Dry AMD
LumiThera - Photobiomodulation Light Therapy for AMD
Long-term efficacy and safety of pegcetacoplan - GALE Trial
C20-D3-Vitamin A Slows Growth of Atrophic Lesions in ABCA4-Related Stargardt Disease, TEASE Study
RPE Cells in a Dish & Stem Cell Transplant from manufactured RPE cells Clinical Trial
Use multi characteristic opsin with capsid free plasmid w laser targeted delivery to repair atrophy
Gene therapy delivers light sensitive MCO into retinal cells with potential to detect ambient light
Concerns with pegcetacoplan injection clinical trial data and under reported adverse side effects
Sustained release griseofulvin / Targeting Ref-1 protein with APX3330 drug as new treatments for AMD
Possible protective properties of Metformin may be beneficial for Macular Degeneration Patients
Axonal guidance signaling pathway confer protection against progression to neovascular disease AMD
Glaucoma, AMD and Vascular Diseases, and the Diversification needed in studies and Clinical Trials,
How AI Is Shaping Therapeutic Biomarkers in Neovascular AMD
Deep-learning automated screening tool for AMD
Home monitoring device for Dry AMD
Stem Cell therapies, where are we now?
Treatment for GA in Dry AMD
Photomodulation Therapy for Dry Macular Degeneration